Found: 116
Select item for more details and to access through your institution.
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01571-z
- By:
- Publication type:
- Article
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 9, p. 947, doi. 10.1001/jamaneurol.2024.2619
- By:
- Publication type:
- Article
The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older People.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00804-9
- By:
- Publication type:
- Article
Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest.
- Published in:
- Critical Care, 2023, v. 27, n. 1, p. 1, doi. 10.1186/s13054-023-04355-3
- By:
- Publication type:
- Article
Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest.
- Published in:
- Intensive Care Medicine, 2021, v. 47, n. 9, p. 984, doi. 10.1007/s00134-021-06481-4
- By:
- Publication type:
- Article
Performance of a guideline-recommended algorithm for prognostication of poor neurological outcome after cardiac arrest.
- Published in:
- Intensive Care Medicine, 2020, v. 46, n. 10, p. 1852, doi. 10.1007/s00134-020-06080-9
- By:
- Publication type:
- Article
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.
- Published in:
- Molecular Neurodegeneration, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13024-024-00707-x
- By:
- Publication type:
- Article
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.
- Published in:
- Molecular Neurodegeneration, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13024-024-00707-x
- By:
- Publication type:
- Article
Disentangling genetic risks for development and progression of Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 8, p. 2604, doi. 10.1093/brain/awae237
- By:
- Publication type:
- Article
Age-related and amyloid-beta-independent tau deposition and its downstream effects.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 8, p. 3192, doi. 10.1093/brain/awad135
- By:
- Publication type:
- Article
emerging era of staging Alzheimer's disease pathology using plasma biomarkers.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 5, p. 1740, doi. 10.1093/brain/awad112
- By:
- Publication type:
- Article
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1580, doi. 10.1093/brain/awac329
- By:
- Publication type:
- Article
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 1, p. 259, doi. 10.1002/acn3.51253
- By:
- Publication type:
- Article
Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 9, p. 1661, doi. 10.1002/acn3.51158
- By:
- Publication type:
- Article
The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 5, p. 776, doi. 10.1002/acn3.51048
- By:
- Publication type:
- Article
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 5, p. 1, doi. 10.15252/emmm.202217123
- By:
- Publication type:
- Article
The genetic regulation of protein expression in cerebrospinal fluid.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216359
- By:
- Publication type:
- Article
Blood‐based biomarkers for Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114408
- By:
- Publication type:
- Article
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 8, p. 1, doi. 10.15252/emmm.202114398
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114022
- By:
- Publication type:
- Article
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Decreased pain sensitivity and alterations of cerebrospinal fluid and plasma inflammatory mediators after total hip arthroplasty in patients with disabling osteoarthritis.
- Published in:
- Pain Practice, 2022, v. 22, n. 1, p. 66, doi. 10.1111/papr.13051
- By:
- Publication type:
- Article
Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest.
- Published in:
- Critical Care, 2024, v. 28, n. 1, p. 1, doi. 10.1186/s13054-024-04889-0
- By:
- Publication type:
- Article
CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriers.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65038-5
- By:
- Publication type:
- Article
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23746-0
- By:
- Publication type:
- Article
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19957-6
- By:
- Publication type:
- Article
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01428-5
- By:
- Publication type:
- Article
Plasma phosphorylated tau 217 in preclinical Alzheimer's disease.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad057
- By:
- Publication type:
- Article
Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad054
- By:
- Publication type:
- Article
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad015
- By:
- Publication type:
- Article
Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE e4 carriers.
- Published in:
- Brain Communications, 2022, v. 4, n. 3, p. 1, doi. 10.1093/braincomms/fcac135
- By:
- Publication type:
- Article
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 8, p. 845, doi. 10.1001/jamaneurol.2024.1612
- By:
- Publication type:
- Article
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 1, p. 69, doi. 10.1001/jamaneurol.2023.4596
- By:
- Publication type:
- Article
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 6, p. 614, doi. 10.1001/jamaneurol.2023.1067
- By:
- Publication type:
- Article
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 4, p. 360, doi. 10.1001/jamaneurol.2022.5272
- By:
- Publication type:
- Article
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 2, p. 149, doi. 10.1001/jamaneurol.2021.4654
- By:
- Publication type:
- Article
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 8, p. 961, doi. 10.1001/jamaneurol.2021.1858
- By:
- Publication type:
- Article
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 2, p. 149, doi. 10.1001/jamaneurol.2020.4201
- By:
- Publication type:
- Article
Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 2, p. 229, doi. 10.1001/jamaneurol.2020.3780
- By:
- Publication type:
- Article
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 8, p. 955, doi. 10.1001/jamaneurol.2020.0989
- By:
- Publication type:
- Article
Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99310-z
- By:
- Publication type:
- Article
Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-81705-7
- By:
- Publication type:
- Article